- Home
- MKZR vs GCTK Comparison
MKZR vs GCTK Comparison
Compare MKZR & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MKZR | GCTK |
|---|---|---|
| Founded | 2012 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 6.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MKZR | GCTK |
|---|---|---|
| Price | $3.75 | $4.90 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 41.8K | 22.6K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | ★ 26.45% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $20,994,778.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.63 | N/A |
| 52 Week Low | $3.26 | $4.22 |
| 52 Week High | $50.00 | $468.00 |
Technical Indicators
Market Signals| Indicator | MKZR | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 41.73 | 36.97 |
| Support Level | $3.65 | $4.85 |
| Resistance Level | $5.00 | $5.21 |
| Average True Range (ATR) | 0.44 | 0.43 |
| MACD | 0.03 | -0.10 |
| Stochastic Oscillator | 19.77 | 5.19 |
Price Performance
Historical ComparisonAbout MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate. It is a real estate investment manager who utilizes an approach to real estate securities, often seeing opportunities that others overlook. Based in Orinda, California, MacKenzie Capital Management has specialized in discounted real estate securities and asset management.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.